ASPIRE- Aspirin to prevent recurrent venous thromboembolism. A multi-centre, randomised, double-blind, placebo-controlled clinical trial examining the efficacy and safety of low-dose aspirin after initial anticoagulation to prevent recurrent venous thromboembolism. (2009 – ongoing)
Sponsored by National Health and Medical Research Council, Australia
|